Samlyn Capital »

Dianthus Therapeutics shares owned by Samlyn Capital

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Samlyn Capital from 13F filings

Historical chart of Samlyn Capital investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Samlyn Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Samlyn Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $36M 431k 83.92

More positions owned by Samlyn Capital

Lpl Financial Holdings (LPLA)
JPMorgan Chase & Co. (JPM)
Primo Brands Corporation Class A Com Shs (PRMB)
Capital One Financial (COF)
Morgan Stanley Com New (MS)
Amazon (AMZN)
Meta Platforms Cl A (META)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Blackrock (BLK)
Liberty Media Corp Del Com Lbty One S C (FWONK)
MercadoLibre (MELI)
MKS Instruments (MKSI)
NVIDIA Corporation (NVDA)
Rb Global (RBA)
Live Nation Entertainment (LYV)

View all positions for Samlyn Capital

Top funds holding Dianthus Therapeutics

FMR
BlackRock
RA Capital Management
Fairmount Funds Management
Wellington Management Company
Avidity Partners Management
Vanguard Group
Vanguard Capital Management
Octagon Capital Advisors
TCG Crossover Management
Citadel Advisors
State Street Corporation
VR Adviser
Fred Alger Management
Deerfield Management Company

View all funds holding Dianthus Therapeutics